Home Ionpath

Ionpath

In operation
Series B
Tissue Imaging Technology Developer

Basic Information

IONpath is revolutionizing tissue imaging to accelerate medical discoveries and improve human health. The company’s MIBIscope system leverages Multiplexed Ion Beam Imaging (MIBI) technology, representing a transformative step in tissue imaging by simultaneously multiplexing over 40 markers at single-cell resolution. Leading research institutions as well as biotech and pharmaceutical companies are utilizing the MIBIscope for immunology, immuno-oncology, and neuroscience research requiring high-fidelity multiplex imaging data. In addition to the MIBIscope system, IONpath empowers R&D initiatives of academic, biotech, and pharmaceutical partners through IONpath Research Services.
Ionpath, Inc.
California,United States of America
15~50 people
January 01, 2014
partnerships@ionpath.com